Robocath Secures €5 Million Funding to Launch R-One™ Robotic Platform Across European Markets

On September 3, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that Robocath had raised €5 million in funding and appointed Lucien Goffart as Chief Executive Officer.

The companies participating in this financing round include Go Capital, NCI, Normandie Participations, M Capital, and Supernova Invest, along with new investors: Unexo, a subsidiary of Crédit Agricole Group, and the innovation fund launched by Caisse d’Epargne Normandie.

Robocath, a medical robotics company founded in 2009 and headquartered in Rouen, France, is dedicated to the development and commercialization of robotic systems for the treatment of cardiovascular diseases. The company will use the proceeds from this financing round to support the launch of its medical robotics platform in strategic target markets across Europe.

Lucien Goffart has 20 years of experience in the field of interventional cardiology and has held many key positions at leading companies in this field. He also excels in supporting the international marketing of new products.

Philippe Bencteux, Founder and President of Robocath, stated, “I am delighted to welcome Lucien Goffart to the company at this pivotal moment as we launch our first medical robotics platform. His experience in this industry is undeniable. I would like to thank our long-standing shareholders, who have once again demonstrated their trust in us by securing this new round of funding. We also extend our gratitude to our new shareholders for their support.”

Robocath CEO Lucien Goffart added, “It is my honor to begin my tenure as CEO of Robocath today.”I have been deeply impressed by the progress the company has made since its inception, and I am delighted to collaborate with such a young and dynamic team.R-One™ is a unique product that offers multiple advantages to both physicians and patients. It holds significant market potential, and I look forward to initiating clinical trials to write a new chapter in the history of interventional cardiology.”

GO CAPITAL is a private equity fund headquartered in Rennes, France. GO CAPITAL is an AMF-approved management company and a member of AFIC. The firm focuses on investing in innovative companies with high growth potential in western France. Go Capital currently manages over €130 million in assets.

NCI is a French venture capital firm that manages over €220 million in assets and currently provides investment to more than 60 companies.

Normandie Participations is the private equity arm of AD Normandie, dedicated to supporting local businesses in their development, innovation, and internationalization.

M Capital Partners is an independent investment management firm, authorized by the Financial Markets Authority (AMF), with a focus on private equity, real estate, and private debt. The firm manages over €5 million in assets and employs more than 40 staff across five offices in France (Paris, Toulouse, Nice, Lyon, and Bordeaux).

Supernova Invest is a French venture capital fund management company focused on investing in enterprises that develop disruptive technologies. Supernova Invest provides funding and support to startups in fields such as life sciences, energy and environment, industry, microelectronics, and digitalization.

Unexo is the private equity arm of Crédit Agricole, focusing on more mature companies. UNEXO primarily operates in regions such as Brittany, Normandy, the Loire Valley, Poitou, and Charente. The company is headquartered in Rennes, with regional offices in Nantes, Caen, and Rouen.

Caisse d’Epargne Normandie serves customers in the Normandy region and is committed to implementing local projects initiated and supported by stakeholders in the field. To strengthen its investment in the digital ecosystem, Caisse d’Epargne Normandie has launched an investment vehicle: the Caisse d’Epargne Normandie Innovation (CEN Innovation) Fund, with a budget of €1 million.

(Compiled by Tian Shuhang)